Atherosclerosis
Volume 205, Issue 2 , Pages 385-390, August 2009

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

  • Majd A.I. Mirza

      Affiliations

    • Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
    • ,
  • Anders Larsson

      Affiliations

    • Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
    • ,
  • Lars Lind

      Affiliations

    • Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
    • ,
  • Tobias E. Larsson

      Affiliations

    • Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
    • Department of Nephrology, Karolinska University Hospital, Stockholm, Sweden
    • Corresponding Author InformationCorresponding author at: Department of Medical Sciences, Uppsala University Hospital, Ing.70, 3 tr, UAS, 75185 Uppsala, Sweden. Tel.: +46 18 611 2657; fax: +46 18 500952.

Received 30 September 2008; received in revised form 28 November 2008; accepted 5 January 2009. published online 02 February 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0021-9150(09)00009-4

doi:10.1016/j.atherosclerosis.2009.01.001

Atherosclerosis
Volume 205, Issue 2 , Pages 385-390, August 2009

Article Tools

* Image Usage & Resolution